Search

Author/Creator Schachter, J.

1. 3301 Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma. (September 2015)

Authors:
Robert, C.; Karaszewska, B.; Schachter, J.; Rutkowski, P.; Mackiewicz, A.; Stroyakovskiy, D.; Lichinitser, M.; Dummer, R.; Grange, F.; Mortier, L.; Chiarion-Sileni, V.; Drucis, K.; Krajsova, I.; Hauschild, A.; Mookerjee, B.; Legos, J.; Schadendorf, D.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067). (September 2015)

Authors:
Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J.J.; Cowey, C.L.; Lao, C.D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M.S.; Wolter, P.; Lebbé, C.; Schachter, J.; Thomas, L.; Hassel, J.C.; Lorigan, P.; Walker, D.; Jiang, J.; Hodi, F.S.; Wolchok, J.D.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 3345 COMBI-v: health-related quality of life (HRQoL) impact of the combination of dabrafenib and trametinib (D+T) vs vemurafenib (V) in patients with BRAF V600 metastatic melanoma (MM). (September 2015)

Authors:
Grob, J.J.; Amonkar, M.; Karaszewska, B.; Schachter, J.; Dummer, R.; Mackiewicz, A.; Stroiakovski, D.; Drucis, K.; Grange, F.; Chiarion-Sileni, V.; Rutkowski, P.; Lichinitser, M.; Levchenko, E.; Wolter, P.; Hauschild, A.; Long, G.V.; Sun, P.; McDowell, D.O.; Mookerjee, B.; Robert, C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. (February 2017)

Authors:
Long, G.V.; Robert, C.; Arance, A.; Blank, C.; Ribas, A.; Lorigan, P.; Mortier, L.; Schachter, J.; Middleton, M.R.; Neyns, B.; Sznol, M.; Zhou, H.; Ebbinghaus, S.; Ibrahim, N.; Steven, N.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of pembrolizumab in patients with advanced mucosal melanoma enrolled in the KEYNOTE-001, 002, and 006 studies. (February 2017)

Authors:
Butler, M.; Hamid, O.; Ribas, A.; Hodi, F.S.; Walpole, E.; Dauad, A.; Arance, A.; Brown, E.; Hoeller, C.; Mortier, L.; Schachter, J.; Long, J.; Ebbinghaus, S.; Ibrahim, N.; Robert, C.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma. (10th January 2013)

Authors:
Klein, M.; Lotem, M.; Peretz, T.; Zwas, S. T.; Mizrachi, S.; Liberman, Y.; Chisin, R.; Schachter, J.; Ron, I. G.; Iosilevsky, G.; Kennedy, J. A.; Revskaya, E.; de Kater, A. W.; Banaga, E.; Klutzaritz, V.; Friedmann, N.; Galun, E.; DeNardo, G. L.; DeNardo, S. J.; Casadevall, A.
Other Names:
Moretti Silvia Academic Editor.
Journal:
Journal of skin cancer
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. (25th November 2015)

Authors:
Ortenberg, R.; Sapoznik, S.; Zippel, D.; Shapira-Frommer, R.; Itzhaki, O.; Kubi, A.; Zikich, D.; Besser, M. J.; Schachter, J.; Markel, G.
Other Names:
Castriconi Roberta Academic Editor.
Journal:
Journal of immunology research
Issue:
Volume 2015(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗